X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-06-16 | DCPH | Flynn Daniel Lee | Chief Scientific Officer | S - Sale | $14.40 | -1,655 | 378,613 | 0% | -$23,835 | ||||||
D | 2023-02-16 | DCPH | Flynn Daniel Lee | Chief Scientific Officer | S - Sale+OE | $15.10 | -1,370 | 380,268 | 0% | -$20,686 | |||||
2023-01-17 | DCPH | Flynn Daniel Lee | Chief Scientific Officer | S - Sale | $21.24 | -2,403 | 365,150 | -1% | -$51,043 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |